Investors

Webcast
Ocular Therapeutix, Inc. at the H.C. Wainwright 22nd Annual Global Investment Conference
Monday, September 14, 2020 1:30 PM EDT
Webcast
Ocular Therapeutix, Inc. at the 2020 Wells Fargo Virtual Healthcare Conference
Thursday, September 10, 2020 4:00 PM EDT
Webcast
Q2 2020 Ocular Therapeutix, Inc. Earnings Conference Call
Friday, August 07, 2020 8:30 AM EDT

Corporate Profile

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Our product pipeline candidates utilize the hydrogel technology to provide differentiated drug delivery solutions that are designed to reduce the complexity and burden of current drop or injection regimens by creati
(Common Stock)

Data Provided by Refinitiv. Minimum 15 minutes delayed.